Regenerating Retinal Pigment Epithelial Cells to Cure Blindness: A Road Towards Personalized Artificial Tissue

Current Stem Cell Reports

Volumn 1, Issue 2, 2015, Pages 79-91

  Jha, Balendu Shekhar ^a   Bharti, Kapil ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

Age related macular degeneration; Blindness; Induced pluripotent stem cells; Retinal dystrophy; Retinal pigment epithelium; Scaffold; Transplantation

Indexed keywords

AGE RELATED MACULAR DEGENERATION; BLINDNESS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL THERAPY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PERSONALIZED MEDICINE; PHOTORECEPTOR; PHOTORECEPTOR OUTER SEGMENT; PIGMENT EPITHELIUM; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SURGICAL TECHNIQUE; TISSUE ENGINEERING; TISSUE SCAFFOLD; TRANSPLANTATION; VISUAL ACUITY;

EID: 84989302977     PISSN: None     EISSN: 21987866     Source Type: Journal    
DOI: 10.1007/s40778-015-0014-4     Document Type: Review

References (133)

1. Resnikoff S, Pascolini D, Etya’ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82(11):844–51.
2. Ambati J, Fowler B. Mechanisms of age-related macular degeneration. Neuron. 2012;75(1):26–39.
3. Gouras P, Lopez R. Transplantation of retinal epithelial cells. Invest Ophthalmol Vis Sci. 1989;30(8):1681–3.
4. Holz FG, Strauss EC, Schmitz-Valckenberg S, van Lookeren Campagne M. Geographic atrophy: clinical features and potential therapeutic approaches. Ophthalmology. 2014;121(5):1079–91.
5. Bharti K, Miller SS, Arnheiter H. The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells. Pigment Cell Melanoma Res. 2011;24(1):21–34.
6. Bharti K, Nguyen MT, Skuntz S, Bertuzzi S, Arnheiter H. The other pigment cell: specification and development of the pigmented epithelium of the vertebrate eye. Pigment Cell Res. 2006;19(5):380–94.
7. Edwards RB, Szamier RB. Defective phagocytosis of isolated rod outer segments by RCS rat retinal pigment epithelium in culture. Science. 1977;197(4307):1001–3.
8. Mazzoni F, Safa H, Finnemann SC. Understanding photoreceptor outer segment phagocytosis: use and utility of RPE cells in culture. Exp Eye Res. 2014;126(0):51–60.
9. Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol. 2004;122(4):598–614.
10. Bird AC, Phillips RL, Hageman GS. Geographic atrophy: a histopathological assessment. JAMA Ophthalmol. 2014;132(3):338–45.
11. Kvanta A, Grudzinska MK. Stem cell-based treatment in geographic atrophy: promises and pitfalls. Acta Ophthalmol. 2014;92(1):21–6.
12. Gouras P, Flood MT, Kjeldbye H. Transplantation of cultured human retinal cells to monkey retina. An Acad Bras Cienc. 1984;56(4):431–43.
13. Lopez R, Gouras P, Brittis M, Kjeldbye H. Transplantation of cultured rabbit retinal epithelium to rabbit retina using a closed-eye method. Invest Ophthalmol Vis Sci. 1987;28(7):1131–7.
14. Lopez R, Gouras P, Kjeldbye H, et al. Transplanted retinal pigment epithelium modifies the retinal degeneration in the RCS rat. Invest Ophthalmol Vis Sci. 1989;30(3):586–8.
15. Li L, Turner JE. Transplantation of retinal pigment epithelial cells to immature and adult rat hosts: short- and long-term survival characteristics. Exp Eye Res. 1988;47(5):771–85.
16. Strauss O, Stumpff F, Mergler S, Wienrich M, Wiederholt M. The Royal College of Surgeons rat: an animal model for inherited retinal degeneration with a still unknown genetic defect. Cells Tissues Organs (Print). 1998;162(2–3):101–11.
17. Li LX, Turner JE. Inherited retinal dystrophy in the RCS rat: prevention of photoreceptor degeneration by pigment epithelial cell transplantation. Exp Eye Res. 1988;47(6):911–7.
18. Sheedlo HJ, Li L, Turner JE. Photoreceptor cell rescue in the RCS rat by RPE transplantation: a therapeutic approach in a model of inherited retinal dystrophy. Prog Clin Biol Res. 1989;314:645–58.
19. Sheedlo HJ, Li L, Turner JE. Functional and structural characteristics of photoreceptor cells rescued in RPE-cell grafted retinas of RCS dystrophic rats. Exp Eye Res. 1989;48(6):841–54.
20. Li L, Sheedlo HJ, Turner JE. Chapter 20. Long-term rescue of photoreceptor cells in the retinas of RCS dystrophic rats by RPE transplants. Prog Brain Res. 1990;82(0):179–85.
21. Li L, Turner JE. Optimal conditions for long-term photoreceptor cell rescue in RCS rats: the necessity for healthy RPE transplants. Exp Eye Res. 1991;52(6):669–79.
22. D’Cruz PM, Yasumura D, Weir J, et al. Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum Mol Genet. 2000;9(4):645–51.
23. Whiteley SJO, Litchfield TM, Coffey PJ, Lund RD. Improvement of the pupillary light reflex of Royal College of Surgeons rats following RPE cell grafts. Exp Neurol. 1996;140(1):100–4.
24. Sauvé Y, Klassen H, Whiteley SJO, Lund RD. Visual field loss in RCS rats and the effect of RPE cell transplantation. Exp Neurol. 1998;152(2):243–50.
25. Lund RD, Adamson P, Sauvé Y, et al. Subretinal transplantation of genetically modified human cell lines attenuates loss of visual function in dystrophic rats. Proceedings of the National Academy of Sciences. 2001;98(17):9942–7.
26. Lund RD, Kwan ASL, Keegan DJ, Sauvé Y, Coffey PJ, Lawrence JM. Cell transplantation as a treatment for retinal disease. Prog Retin Eye Res. 2001;20(4):415–49.
27. Lund RD, Ono SJ, Keegan DJ, Lawrence JM. Retinal transplantation: progress and problems in clinical application. J Leukoc Biol. 2003;74(2):151–60.
28. Algvere PV, Berglin L, Gouras P, Sheng Y. Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Graefes Arch Clin Exp Ophthalmol. 1994;232(12):707–16.
29. Algvere PV, Berglin L, Gouras P, Sheng Y, Kopp ED. Transplantation of RPE in age-related macular degeneration: observations in disciform lesions and dry RPE atrophy. Graefes Arch Clin Exp Ophthalmol. 1997;235(3):149–58.
30. Weisz JM, Humayun MS, Eugene de Juan J, et al. Allogenic fetal retinal pigment epithelial cell transplant in a patient with geographic atropy. Retina. 1999;19(6):540–5.
31. Peyman GA, Blinder KJ, Paris CL, Alturki W, Nelson Jr NC, Desai U. A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring. Ophthalmic Surg. 1991;22(2):102–8.
32. Zarbin M, Sugino I, Castellarin A, Fine S, Berger J, Maguire M. RPE transplantation for age-related macular degeneration. Age-related macular Degeneration. Philadelphia: Mosby Year Book Inc; 1999. p. 363–82.
33. Del Priore LV, Kaplan HJ, Tezel TH, Hayashi N, Berger AS, Green WR. Retinal pigment epithelial cell transplantation after subfoveal membranectomy in age-related macular degeneration: clinicopathologic correlation. Am J Ophthalmol. 2001;131(4):472–80.
34. Tezel TH, Del Priore LV, Berger AS, Kaplan HJ. Adult retinal pigment epithelial transplantation in exudative age-related macular degeneration. Am J Ophthalmol. 2007;143(4):584–95. e2.
35. Radtke ND, Aramant RB, Petry HM, Green PT, Pidwell DJ, Seiler MJ. Vision improvement in retinal degeneration patients by implantation of retina together with retinal pigment epithelium. Am J Ophthalmol. 2008;146(2):172–82. e1.
36. Algvere PV, Gouras P, Dafgard Kopp E. Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD. Eur J Ophthalmol. 1999;9(3):217–30.
37. Morohoshi K, Goodwin AM, Ohbayashi M, Ono SJ. Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration. J Autoimmun. 2009;33(3):247–54.
38. Rezai KA, Semnani RT, Patel SC, Ernest JT, van Seventer GA. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation. Invest Ophthalmol Vis Sci. 1997;38(12):2662–71.
39. Kohen L, Enzmann V, Faude F, Wiedemann P. Mechanisms of graft rejection in the transplantation of retinal pigment epithelial cells. Ophthalmic Res. 1997;29(5):298–304.
40. Binder S, Stanzel BV, Krebs I, Glittenberg C. Transplantation of the RPE in AMD. Prog Retin Eye Res. 2007;26(5):516–54.
41. da Cruz L, Chen FK, Ahmado A, Greenwood J, Coffey P. RPE transplantation and its role in retinal disease. Prog Retin Eye Res. 2007;26(6):598–635.
42. Binder S, Stolba U, Krebs I, et al. Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration: a pilot study. Am J Ophthalmol. 2002;133(2):215–25.
43. Binder S, Krebs I, Hilgers RD, et al. Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial. Invest Ophthalmol Vis Sci. 2004;45(11):4151–60.
44. Tezel TH, Del Priore LV, Kaplan HJ. Reengineering of aged Bruch’s membrane to enhance retinal pigment epithelium repopulation. Invest Ophthalmol Vis Sci. 2004;45(9):3337–48.
45. Tezel TH, Kaplan HJ, Del Priore LV. Fate of human retinal pigment epithelial cells seeded onto layers of human Bruch’s membrane. Invest Ophthalmol Vis Sci. 1999;40(2):467–76.
46. Diniz B, Thomas P, Thomas B, et al. Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: improved survival when implanted as a monolayer. Invest Ophthalmol Vis Sci. 2013;54(7):5087–96. This is the first report that compared long-term survival of monolayer RPE sheet on a scaffold versus RPE cell suspension in a rodent model. Authors show that monolayer RPE sheet survives longer compared to the cell suspension which forms aggregates when transplanted in the sub-retinal space.
47. Lane C, Boulton M, Marshall J. Transplantation of retinal pigment epithelium using a pars plana approach. Eye (Lond). 1989;3(Pt 1):27–32.
48. van Meurs JC, ter Averst E, Hofland LJ, et al. Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes. Br J Ophthalmol. 2004;88(1):110–3.
49. Stanga PE, Kychenthal A, Fitzke FW, et al. Retinal pigment epithelium translocation and central visual function in age related macular degeneration: preliminary results. Int Ophthalmol. 2001;23(4–6):297–307.
50. MacLaren RE, Bird AC, Sathia PJ, Aylward GW. Long-term results of submacular surgery combined with macular translocation of the retinal pigment epithelium in neovascular age-related macular degeneration. Ophthalmology. 2005;112(12):2081–7.
51. Joussen AM, Heussen FMA, Joeres S, et al. Autologous translocation of the choroid and retinal pigment epithelium in age-related macular degeneration. Am J Ophthalmol. 2006;142(1):17–30. e8.
52. Ma Z, Han L, Wang C, et al. Autologous transplantation of retinal pigment epithelium–Bruch’s membrane complex for hemorrhagic age-related macular degeneration. Invest Ophthalmol Vis Sci. 2009;50(6):2975–81.
53. Bindewald A, Roth F, Van Meurs J, Holz FG. Transplantation of retinal pigment pithelium (RPE) following CNV removal in patients with AMD. Techniques, results, outlook. Ophthalmologe. 2004;101(9):886–94.
54. MacLaren RE, Uppal GS, Balaggan KS, et al. Autologous transplantation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degeneration. Ophthalmology. 2007;114(3):561–70.
55. Treumer F, Bunse A, Klatt C, et al. Autologous retinal pigment epithelium–choroid sheet transplantation in age related macular degeneration: morphological and functional results. Br J Ophthalmol. 2007;91(3):349–53.
56. Joussen AM, Joeres S, Fawzy N, et al. Autologous translocation of the choroid and retinal pigment epithelium in patients with geographic atrophy. Ophthalmology. 2007;114(3):551–60.
57. van Zeeburg EJ, Maaijwee KJ, Missotten TO, Heimann H, van Meurs JC. A free retinal pigment epithelium–choroid graft in patients with exudative age-related macular degeneration: results up to 7 years. Am J Ophthalmol. 2012;153(1):120–7. e2.
58. Maaijwee K, Heimann H, Missotten T, Mulder P, Joussen A, van Meurs J. Retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: long-term results. Graefes Arch Clin Exp Ophthalmol. 2007;245(11):1681–9.
59. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145–7.
60. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861–72.
61. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917–20.
62. Hong S, Winkler T, Wu C, et al. Path to the clinic: assessment of iPSC-based cell therapies in vivo in a nonhuman primate model. Cell Rep. 2014;7(4):1298–309.
63. Kawasaki H, Suemori H, Mizuseki K, et al. Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity. Proc Natl Acad Sci USA. 2002;99(3):1580–5.
64. Haruta M, Sasai Y, Kawasaki H, et al. In vitro and in vivo characterization of pigment epithelial cells differentiated from primate embryonic stem cells. Invest Ophthalmol Vis Sci. 2004;45(3):1020–5.
65. Klimanskaya I, Hipp J, Rezai KA, West M, Atala A, Lanza R. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells. 2004;6(3):217–45.
66. Osakada F, Ikeda H, Sasai Y, Takahashi M. Stepwise differentiation of pluripotent stem cells into retinal cells. Nat Protoc. 2009;4(6):811–24.
67. Idelson M, Alper R, Obolensky A, et al. Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell. 2009;5(4):396–408.
68. Reh TA, Lamba D, Gust J. Directing human embryonic stem cells to a retinal fate. Cellular Programming and Reprogramming. 2010;636:139–53.
69. Lane A, Philip LR, Ruban L, et al. Engineering efficient retinal pigment epithelium differentiation from human pluripotent stem cells. Stem Cells Transl Med. 2014;3(11):1295–304.
70. Vaajasaari H, Ilmarinen T, Juuti-Uusitalo K, et al. Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells. Mol Vis. 2011;17:558–75.
71. Buchholz DE, Pennington BO, Croze RH, Hinman CR, Coffey PJ, Clegg DO. Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium. Stem Cells Transl Med. 2013;2(5):384–93.
72. Lund RD, Wang S, Klimanskaya I, et al. Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells. 2006;8(3):189–99.
73. Schwartz SD, Hubschman J, Heilwell G, et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet. 2012;379(9817):713–20.
74. Lu B, Malcuit C, Wang S, et al. Long‐term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells. 2009;27(9):2126–35.
75. Carr A, Vugler AA, Hikita ST, et al. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One. 2009;4(12):e8152.
76. Hu Y, Liu L, Lu B, et al. A novel approach for subretinal implantation of ultrathin substrates containing stem cell-derived retinal pigment epithelium monolayer. Ophthalmic Res. 2012;48(4):186–91.
77. Schwartz SD, Regillo CD, Lam BL, et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet. 2015;385:509–16.
78. Ho TC, Del Priore LV. Reattachment of cultured human retinal pigment epithelium to extracellular matrix and human Bruch’s membrane. Invest Ophthalmol Vis Sci. 1997;38(6):1110–8.
79. Pruett RC, Weiter JJ, Goldstein RB. Myopic cracks, angioid streaks, and traumatic tears in Bruch’s membrane. Am J Ophthalmol. 1987;103(4):537–43.
80. Bhatt NS, Newsome DA, Fenech T, et al. Experimental transplantation of human retinal pigment epithelial cells on collagen substrates. Am J Ophthalmol. 1994;117(2):214–21.
81. Thumann G, Hueber A, Dinslage S, et al. Characteristics of iris and retinal pigment epithelial cells cultured on collagen type I membranes. Curr Eye Res. 2006;31(3):241–9.
82. Lu JT, Lee CJ, Bent SF, Fishman HA, Sabelman EE. Thin collagen film scaffolds for retinal epithelial cell culture. Biomaterials. 2007;28(8):1486–94.
83. Del Priore LV, Tezel TH, Kaplan HJ. Survival of allogeneic porcine retinal pigment epithelial sheets after subretinal transplantation. Invest Ophthalmol Vis Sci. 2004;45(3):985–92.
84. Ho T, Del Priore LV, Kaplan HJ. En bloc transfer of extracellular matrix in vitro. Curr Eye Res. 1996;15(9):991–7.
85. Oganesian A, Gabrielian K, Ernest JT, Patel SC. A new model of retinal pigment epithelium transplantation with microspheres. Arch Ophthalmol. 1999;117(9):1192–200.
86. Sugino IK, Sun Q, Wang J, et al. Comparison of FRPE and human embryonic stem cell-derived RPE behavior on aged human Bruch’s membrane. Invest Ophthalmol Vis Sci. 2011;52(8):4979–97.
87. Thumann G, Schraermeyer U, Bartz-Schmidt KU, Heimann K. Descemet’s membrane as membranous support in RPE/IPE transplantation. Curr Eye Res. 1997;16(12):1236–8.
88. Hartmann U, Sistani F, Steinhorst U. Human and porcine anterior lens capsule as support for growing and grafting retinal pigment epithelium and iris pigment epithelium. Graefes Arch Clin Exp Ophthalmol. 1999;237(11):940–5.
89. Nicolini J, Kiilgaard JF, Wiencke AK, et al. The anterior lens capsule used as support material in RPE cell‐transplantation. Acta Ophthalmol Scand. 2000;78(5):527–31.
90. Lee CJ, Huie P, Leng T, et al. Microcontact printing on human tissue for retinal cell transplantation. Arch Ophthalmol. 2002;120(12):1714–8.
91. Farrokh-Siar L, Rezai KA, Patel SC, Ernest TT. Cryoprecipitate: an autologous substrate for human fetal retinal pigment epithelium. Curr Eye Res. 1999;19(2):89–94.
92. Capeans C, Pineiro A, Pardo M, et al. Amniotic membrane as support for human retinal pigment epithelium (RPE) cell growth. Acta Ophthalmol Scand. 2003;81(3):271–7.
93. Singhal S, Vemuganti GK. Primary adult human retinal pigment epithelial cell cultures on human amniotic membranes. Indian J Ophthalmol. 2005;53(2):109–13.
94. Stanzel BV, Espana EM, Grueterich M, et al. Amniotic membrane maintains the phenotype of rabbit retinal pigment epithelial cells in culture. Exp Eye Res. 2005;80(1):103–12.
95. Ohno-Matsui K, Ichinose S, Nakahama K, et al. The effects of amniotic membrane on retinal pigment epithelial cell differentiation. Mol Vis. 2005;11(6):1–10.
96. Beutel J, Greulich L, Lüke M, et al. Inner limiting membrane as membranous support in RPE sheet-transplantation. Graefes Arch Clin Exp Ophthalmol. 2007;245(10):1469–73.
97. Shadforth A, George KA, Kwan AS, Chirila TV, Harkin DG. The cultivation of human retinal pigment epithelial cells on < i > Bombyx mori silk fibroin. Biomaterials. 2012;33(16):4110–7.
98. Xiang P, Wu K, Zhu Y, et al. A novel Bruch’s membrane-mimetic electrospun substrate scaffold for human retinal pigment epithelium cells. Biomaterials. 2014;35:9777–88.
99. Liu Z, Yu N, Holz FG, Yang F, Stanzel BV. Enhancement of retinal pigment epithelial culture characteristics and subretinal space tolerance of scaffolds with 200 nm fiber topography. Biomaterials. 2014;35(9):2837–50.
100. Treharne AJ, Thomson HAJ, Grossel MC, Lotery AJ. Developing methacrylate-based copolymers as an artificial Bruch’s membrane substitute. J Biomed Mater Res A. 2012;100A(9):2358–64.
101. Srivastava GK, Martín L, Singh AK, et al. Elastin‐like recombinamers as substrates for retinal pigment epithelial cell growth. J Biomed Mater Res A. 2011;97(3):243–50.
102. Singh AK, Srivastava GK, Martín L, Alonso M, Pastor JC. Bioactive substrates for human retinal pigment epithelial cell growth from elastin‐like recombinamers. J Biomed Mater Res A. 2014;102(3):639–46.
103. Thomson RC, Giordano GG, Collier JH, et al. Manufacture and characterization of poly (α-hydroxy ester) thin films as temporary substrates for retinal pigment epithelium cells. Biomaterials. 1996;17(3):321–7.
104. Giordano GG, Thomson RC, Ishaug SL, et al. Retinal pigment epithelium cells cultured on synthetic biodegradable polymers. J Biomed Mater Res. 1997;34(1):87–93.
105. Hadlock T, Singh S, Vacanti J, McLaughlin BJ. Ocular cell monolayers cultured on biodegradable substrates. Tissue Eng. 1999;5(3):187–96.
106. Lu L, Garcia CA, Mikos AG. Retinal pigment epithelium cell culture on thin biodegradable poly (DL-lactic-co-glycolic acid) films. J Biomater Sci Polym Ed. 1998;9(11):1187–205.
107. Williams R, Krishna Y, Dixon S, Haridas A, Grierson I, Sheridan C. Polyurethanes as potential substrates for sub-retinal retinal pigment epithelial cell transplantation. J Mater Sci Mater Med. 2005;16(12):1087–92.
108. Carr AF, Smart MJK, Ramsden CM, Powner MB, da Cruz L, Coffey PJ. Development of human embryonic stem cell therapies for age-related macular degeneration. Trends Neurosci. 2013;36(7):385–95.
109. Stanzel BV, Liu Z, Brinken R, Braun N, Holz FG, Eter N. Subretinal delivery of ultrathin rigid-elastic cell carriers using a metallic shooter instrument and biodegradable hydrogel encapsulation. Invest Ophthalmol Vis Sci. 2012;53(1):490–500. In this report authors use a special transplantation device that allows an easier and reproducible transplantation of RPE tissue in the sub-retinal space in animal models. Such tool will facilitate pre-clinical work with novel RPE tissues developed by investigators.
110. Stanzel BV, Liu Z, Somboonthanakij S, et al. Human RPE stem cells grown into polarized RPE monolayers on a polyester matrix are maintained after grafting into rabbit subretinal space. Stem Cell Rep. 2014;2(1):64–77.
111. Sorkio A, Hongisto H, Kaarniranta K, Uusitalo H, Juuti-Uusitalo K, Skottman H. Structure and barrier properties of human embryonic stem cell-derived retinal pigment epithelial cells are affected by extracellular matrix protein coating. Tissue Eng Part A. 2014;20(3–4):622–34.
112. Tezcaner A, Bugra K, Hasırcı V. Retinal pigment epithelium cell culture on surface modified poly (hydroxybutyrate-co-hydroxyvalerate) thin films. Biomaterials. 2003;24(25):4573–83.
113. Krishna Y, Sheridan C, Kent D, Kearns V, Grierson I, Williams R. Expanded polytetrafluoroethylene as a substrate for retinal pigment epithelial cell growth and transplantation in age-related macular degeneration. Br J Ophthalmol. 2011;95(4):569–73.
114. McHugh KJ, Tao SL, Saint-Geniez M. Porous poly(epsilon-caprolactone) scaffolds for retinal pigment epithelium transplantation. Invest Ophthalmol Vis Sci. 2014;55(3):1754–62.
115. Lu B, Tai YC, Humayun MS. Microdevice-based cell therapy for age-related macular degeneration. Dev Ophthalmol. 2014;53:155–66.
116. Wu H, Li X, Dong J, Pei W, Chen H. Effects of subretinal implant materials on the viability, apoptosis and barrier function of cultured RPE cells. Graefes Arch Clin Exp Ophthalmol. 2007;245(1):135–42.
117. Subrizi A, Hiidenmaa H, Ilmarinen T, et al. Generation of hESC-derived retinal pigment epithelium on biopolymer coated polyimide membranes. Biomaterials. 2012;33(32):8047–54.
118. Binder S. Scaffolds for retinal pigment epithelium (RPE) replacement therapy. Br J Ophthalmol. 2011;95(4):441–2.
119. Hynes SR, Lavik EB. A tissue-engineered approach towards retinal repair: scaffolds for cell transplantation to the subretinal space. Graefes Arch Clin Exp Ophthalmol. 2010;248(6):763–78.
120. Treharne AJ, Grossel MC, Lotery AJ, Thomson HA. The chemistry of retinal transplantation: the influence of polymer scaffold properties on retinal cell adhesion and control. Br J Ophthalmol. 2011;95(6):768–73.
121. Sponsor Institutes: Pfizer and University College London. A study of implantation of human embryonic stem cell derived retinal pigment epithelium in subjects with acute wet age related macular degeneration and recent rapid vision decline. http://www.clinicaltrials.gov/ct2/show/NCT01691261?term=rpe&rank=11. Accessed 11/16 2014.
122. Kamao H, Mandai M, Okamoto S, et al. Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Rep. 2014;2(2):205–18. This is the first report testing autologous and allogeneic iPSC-derived RPE sheets in monkey models. Authors were able to transplant RPE sheets without any additional scaffold. They demonstrate that autologous cells have better survival in monkey models. This work led to the first in human iPSC-derived RPE sheet transplant in 2014.
123. Reardon S, Cyranoski D. Japan stem-cell trial stirs envy. Nature. 2014;513(7518):287–8.
124. Kubota A, Nishida K, Yamato M, et al. Transplantable retinal pigment epithelial cell sheets for tissue engineering. Biomaterials. 2006;27(19):3639–44.
125. von Recum HA, Okano T, Kim SW, Bernstein PS. Maintenance of retinoid metabolism in human retinal pigment epithelium cell culture. Exp Eye Res. 1999;69(1):97–107.
126. von Recum H, Kikuchi A, Yamato M, Sakurai Y, Okano T, Kim SW. Growth factor and matrix molecules preserve cell function on thermally responsive culture surfaces. Tissue Eng. 1999;5(3):251–65.
127. Yaji N, Yamato M, Yang J, Okano T, Hori S. Transplantation of tissue-engineered retinal pigment epithelial cell sheets in a rabbit model. Biomaterials. 2009;30(5):797–803.
128. Riolobos L, Hirata RK, Turtle CJ, et al. HLA engineering of human pluripotent stem cells. Mol Ther. 2013;21(6):1232–41.
129. Andrews PW, Cavanagro, J, Deans, R, et al. Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells. Nat Biotechnol. 2014;32:724–6.
130. Turner M, Leslie S, Martin NG, et al. Toward the development of a global induced pluripotent stem cell library. Cell Stem Cell. 2013;13(4):382–4.
131. Eiraku M, Takata N, Ishibashi H, et al. Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature. 2011;472(7341):51–6.
132. Zhong X, Gutierrez C, Xue T, et al. Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs. Nat Commun. 2014;5:4047.
133. Bharti K, Rao M, Hull SC, et al. Developing cellular therapies for retinal degenerative diseases. Invest Ophthalmol Vis Sci. 2014;55(2):1191–202.